Hakutulokset - Matthias A. Karajannis

Tarkenna hakua
  1. 1
    Neurofibromatosis-related tumors

    Neurofibromatosis-related tumors Tekijä Matthias A. Karajannis, Rosalie E. Ferner

    Julkaistu 2014
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Treatment of pediatric brain tumors

    Treatment of pediatric brain tumors Tekijä Matthias A. Karajannis, Jeffrey C. Allen, Elizabeth W. Newcomb

    Julkaistu 2008
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Glioblastoma multiforme: State of the art and future therapeutics

    Glioblastoma multiforme: State of the art and future therapeutics Tekijä DavidH. Harter, TaylorA Wilson, Matthias A. Karajannis

    Julkaistu 2014
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Strict Lymphotropism of Epstein-Barr Virus During Acute Infectious Mononucleosis in Nonimmunocompromised Individuals

    Strict Lymphotropism of Epstein-Barr Virus During Acute Infectious Mononucleosis in Nonimmunocompromised Individuals Tekijä Matthias A. Karajannis, Michael Hummel, I. Anagnostopoulos, H. Stein

    Julkaistu 1997
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus

    Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus Tekijä Wei Li, Jonathan M. Cooper, Matthias A. Karajannis, Filippo G. Giancotti

    Julkaistu 2012
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma

    R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma Tekijä Susan Williams, Matthias A. Karajannis, Luis Chiriboga, John G. Golfinos, Andreas von Deimling, David Zagzag

    Julkaistu 2010
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape

    Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape Tekijä Amar Gajjar, Daniel C. Bowers, Matthias A. Karajannis, Sarah Leary, Hendrik Witt, Nicholas G. Gottardo

    Julkaistu 2015
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Treatment of Pediatric Low-Grade Gliomas

    Treatment of Pediatric Low-Grade Gliomas Tekijä Sameer Farouk Sait, Alexandra Giantini-Larsen, Kathryn R. Tringale, Mark M. Souweidane, Matthias A. Karajannis

    Julkaistu 2023
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors

    Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors Tekijä Shiyang Wang, Benjamin Liechty, Seema Patel, Jeffrey S. Weber, Travis J. Hollmann, Matija Snuderl, Matthias A. Karajannis

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma

    ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma Tekijä Sylwia Ammoun, Clare H. Cunliffe, Jeffrey C. Allen, Luis Chiriboga, Filippo G. Giancotti, David Zagzag, C. Oliver Hanemann, Matthias A. Karajannis

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation

    Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation Tekijä Cordelia Orillac, Cheddhi Thomas, Yosef Dastagirzada, Eveline Teresa Hidalgo, John G. Golfinos, David Zagzag, Jeffrey H. Wisoff, Matthias A. Karajannis, Matija Snuderl

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2

    MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2 Tekijä Cheng‐Ying Ho, Eli E. Bar, Caterina Giannini, Luigi Marchionni, Matthias A. Karajannis, David Zagzag, David H. Gutmann, Charles G. Eberhart, Fausto J. Rodriguez

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death

    The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death Tekijä Isabelle Petit, Matthias A. Karajannis, Loi͏̈c Vincent, Lauren M. Young, Jason M. Butler, Andrea T. Hooper, Koji Shido, Hermann Steller, David J. Chaplin, Eric J. Feldman, Shahin Rafii

    Julkaistu 2007
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    <i>BRAF</i>Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549

    <i>BRAF</i>Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549 Tekijä Alex Y. Lin, Fausto J. Rodríguez, Matthias A. Karajannis, Susan Williams, Geneviève Legault, David Zagzag, Peter C. Burger, Jeffrey C. Allen, Charles G. Eberhart, Eli E. Bar

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Bevacizumab in recurrent high-grade pediatric gliomas

    Bevacizumab in recurrent high-grade pediatric gliomas Tekijä A. Narayana, Saroj Kunnakkat, Jeena Chacko-Mathew, Sharon L. Gardner, Matthias A. Karajannis, Shahzad Raza, Jeffrey H. Wisoff, Howard L. Weiner, David H. Harter, Jeffrey C. Allen

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus

    Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus Tekijä Wei Li, Jonathan M. Cooper, Lü Zhou, Chenyi Yang, Hediye Erdjument‐Bromage, David Zagzag, Matija Snuderl, Marc Ladanyi, C. Oliver Hanemann, Pengbo Zhou, Matthias A. Karajannis, Filippo G. Giancotti

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target

    Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target Tekijä Marianne Hütt-Cabezas, Matthias A. Karajannis, David Zagzag, Smit Shah, Iren Horkayne‐Szakaly, Elisabeth J. Rushing, J. Douglas Cameron, Deepali Jain, Charles G. Eberhart, Eric H. Raabe, Fausto J. Rodríguez

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas

    Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas Tekijä Matthias A. Karajannis, Geneviève Legault, Mari Hagiwara, Marc Ballas, Krysten Brown, Annette O. Nusbaum, Tsivia Hochman, Judith D. Goldberg, Kevin M. Koch, John G. Golfinos, J. Thomas Roland, Jeffrey C. Allen

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas

    Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas Tekijä Matthias A. Karajannis, Geneviève Legault, Mari Hagiwara, Filippo G. Giancotti, Alexander S. Filatov, Anna Derman, Tsivia Hochman, Judith D. Goldberg, Emilio Vega-Gonzales, Jeffrey H. Wisoff, John G. Golfinos, Amanda Merkelson, J. Thomas Roland, Jeffrey C. Allen

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway

    Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alteratio... Tekijä Jason T. Huse, Matija Snuderl, David Jones, Carole Brathwaite, Nolan Altman, Ehud Lavi, Richard Saffery, Alexandra Sexton‐Oates, Ingmar Blümcke, David Capper, Matthias A. Karajannis, Ryma Benayed, Lukas Chávez, Cheddhi Thomas, Jonathan Serrano, Laetitia Borsu, Marc Ladanyi, Marc K. Rosenblum

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: